Gradin K, Persson B
Department of Pharmacology, Karolinska Institute, Stockholm, Sweden.
J Neural Transm Gen Sect. 1992;87(3):199-213. doi: 10.1007/BF01245366.
Intrathecal (i.th.) administration of substance P (SP, 6.5 nmol) at the Th 8-10 level in conscious rats increased blood pressure (carotid artery), heart rate and plasma catecholamine concentrations. The responses were antagonized by the intravenous (i.v.) but not i.th. pretreatment with the 5-HT2-receptor antagonists ketanserin and ritanserin and intrathecally administered serotonin (5-HT, 10 micrograms). The pressor response and the increase in plasma noradrenaline concentrations were also antagonized by i.v. or i.th. pretreatment with the 5-HT1A-agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). In contrast the pressor response to SP was facilitated by the 5-HT1A-antagonist 1-pindolol (i.v. or i.th). Pretreatment with SP (i.th) reduced the hypotensive response to i.v. 8-OH-DPAT. These results demonstrate functional interactions between SP and serotonergic mechanisms in the central system, but the precise location and nature were not elucidated.
在清醒大鼠的胸8 - 10水平鞘内注射P物质(SP,6.5纳摩尔)可使血压(颈动脉)、心率和血浆儿茶酚胺浓度升高。静脉注射(i.v.)而非鞘内注射5 - HT2受体拮抗剂酮色林和利坦色林以及鞘内注射血清素(5 - HT,10微克)预处理可拮抗这些反应。静脉注射或鞘内注射5 - HT1A激动剂8 - 羟基 - 2 -(二正丙基氨基)四氢萘(8 - OH - DPAT)预处理也可拮抗升压反应和血浆去甲肾上腺素浓度的升高。相反,5 - HT1A拮抗剂1 - 吲哚洛尔(静脉注射或鞘内注射)可促进对SP的升压反应。鞘内注射SP预处理可降低静脉注射8 - OH - DPAT的降压反应。这些结果表明中枢系统中SP与5 - 羟色胺能机制之间存在功能相互作用,但具体位置和性质尚不清楚。